Vibrant Medical Limited

	Page
Balance Sheet	1
Notes to the Financial Statements	2—3

Registered number: 03851907

		2024		2023
	Notes	£	£	£	£
FIXED ASSETS

CURRENT ASSETS
Debtors	4	31,934		35,751

		31,934		35,751
Creditors: Amounts Falling Due Within One Year	5	(1,241,842 )		(1,192,573 )

NET CURRENT ASSETS (LIABILITIES)			(1,209,908 )		(1,156,822 )

TOTAL ASSETS LESS CURRENT LIABILITIES			(1,209,908 )		(1,156,822 )

NET LIABILITIES			(1,209,908 )		(1,156,822 )

CAPITAL AND RESERVES
Called up share capital	6		325,434		325,434
Profit and Loss Account			(1,535,342 )		(1,482,256 )

SHAREHOLDERS' FUNDS			(1,209,908)		(1,156,822)

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Philip Ellin

Director

15 September 2025

The notes on pages 2 to 3 form part of these financial statements.

1. General Information

Vibrant Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 03851907 . The registered office is Unit 1 Colomendy Industrial Estate, Rhyl Road, Denbigh, Denbighshire, Clwyd, LL16 5TS.

The presentation currency of the financial statements is the Pound Sterling (£).

Accounts are rounded to the nearest pound.

The accounts represent the company as an individual entity.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Going Concern Disclosure

The company's business activities, together with the factors likely to affect its future development and position, are set out in the Business Review section of the directors report in the consolidated financial statements.

The company had net liabilities at the end of the year. The company participates in the group's centralised treasury arrangements and so shares banking arrangements with its parent and fellow subsidiaries.

The directors, having assessed the responses of the directors of the company's parent NHC Holdings Limited to their enquiries have no reason to believe that a material uncertainty exists that may cast significant doubt about the ability of the NHC Holdings Limited group to continue as a going concern or its ability to continue with the

current banking arrangements.

On the basis of their assessment of the company's financial position and of the enquiries made of the directors of NHC Holdings Limited, the company directors have a reasonable expectation that the company will be able to continue in operational existence for the foreseeable future. Thus the going concern basis of accounting in

preparing the annual financial statements has been used.

The ultimate parent company NHC Holdings Limited has confirmed its intention to support the company in meeting its liabilities as they fall due, and consequently the financial statements have been prepared on the going concern basis.

2.3. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.

2.4. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Fixtures & Fittings

at varying rates on cost

2.5. Research and development

Expenditure on research and development is written off in the year in which it is incurred.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 4 (2023: 4)

Page 2

Page 3

Vibrant Medical Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2024

4. Debtors

	2024	2023
	£	£
Due within one year
Trade debtors	1,397	4,731
Amounts owed by group undertakings	(483)	-
Other debtors	31,020	31,020

	31,934	35,751

5. Creditors: Amounts Falling Due Within One Year

	2024	2023
	£	£
Trade creditors	1	(1 )
Amounts owed to group undertakings	1,240,491	1,191,199
Taxation and social security	1,350	1,375

	1,241,842	1,192,573

6. Share Capital

	2024	2023
	£	£
Allotted, Called up and fully paid	325,434	325,434

7. Contingent Liabilities

The company has given composite cross guarantees relating to the bank borrowing of certain subsidiary companies. These borrowings amounted to £nil at the year end.

8. FRC's Ethical Standard - Provision Available for Small Entities

In common with other businesses of our size and nature we use our auditors to prepare and submit returns to the tax authorities and assist with the preparation of the financial statements.

9. Audit Information

The auditor's report on the accounts of Vibrant Medical Limited for the year ended 31 December 2024 was unqualified.

The auditor's report was signed by K Wood (Senior Statutory Auditor) for and on behalf of JWR Audit Limited , Statutory Auditor.

Page 3